Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Phase I EGFR BATs in Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Spectral Analysis Probe to Identify Glioblastoma Cells
- Status
- TERMINATED
- Phase
- N/A
Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- N/A
Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
- Status
- COMPLETED
- Phase
- NA
TTFields In GErmany in Routine Clinical Care
- Status
- UNKNOWN
- Phase
- N/A
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Mind-Body Intervention in Glioma Couples
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
HMPL-813 in Treating Patients With Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2